ESCMID weekly news 06.09.2022


Having trouble viewing this email? View in your browser.


 

Weekly News
6 September 2022



Dear colleagues,

Please find below the latest edition of ESCMID Weekly News.

With kind regards,
ESCMID Executive Office.


 

Register now for ESCMID/Ecraid Postgraduate Course

The purpose of the workshop is to provide the participants with tools on how to phrase a research question; choose the appropriate design and methods to address it; avoid biases; and write an optimal report. Find out more about the programme here.

 


 


Call for funded Observerships approaching!

New call for 50 funded observerships will open on 13 September - 20 October. Don't miss this opportunity to perform cutting edge clinical and scientific activities in renowned centres, and make new friends and colleagues. Find the ECC that suits you and get your endorsement letter!

Register for
IMMEM XIII starting on 14 September

The international scientific community of epidemiological surveillance is gathering on 14-17 September for IMMEM XIII in Bath, UK. Register now and follow ESGEM on twitter who will be live tweeting the event!


ESCMID course video introduction

Dr. Arjana Tambić-Andrašević introduces the upcoming ESCMID postgraduate course in Šibenik, Croatia "Clinical microbiology testing in settings with limited resources and high prevalence of antimicrobial resistance: the role of diagnostic stewardship". See the full programme here.

Open Access: Genomic population structures of microbial pathogens

Royal Society Publishing has recently published a special OPEN ACCESS issue of Philosophical Transactions B: Genomic population structures of microbial pathogens; organized and edited by Mark Achtman, David Aanensen and Kathryn Holt - articles are FREE to access directly.


Clinical characteristics of monkeypox virus infection

This study describes the clinical characteristics and complications of patients with a monkeypox infection. The authors found the current outbreak has specific characteristics outlined in the article below. Click below to read the full article.

New workplan to the Accelerate Clinical Trials

European Commission (EC), Heads of Medicines Agencies and European Medicines Agency (EMA) have published the 2022-2026 workplan of the Accelerate Clinical Trials in the EU (ACT EU) initiative, based on recommendations from EMA network strategy to 2025 and EC Pharmaceutical Strategy for Europe.


European Medicines Agency survey on communication with the public

EMA is carrying out a survey to assess how communications are more effective to the general public. This will provide valuable feedback to improve communication activities with all stakeholders and partners.



 




 

 

 

Nahoru